Latest Insider Transactions at Teladoc Health, Inc. (TDOC)
This section provides a real-time view of insider transactions for Teladoc Health, Inc. (TDOC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Teladoc Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Teladoc Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 30
2020
|
Arnnon Geshuri CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,911
+50.0%
|
-
|
|
Oct 06
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-4.3%
|
$6,660,000
$222.26 P/Share
|
|
Oct 06
2020
|
Jason N Gorevic CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.12%
|
$180,000
$6.01 P/Share
|
|
Oct 05
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
2,610
-92.88%
|
$579,420
$222.46 P/Share
|
|
Oct 05
2020
|
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
2,610
+38.03%
|
$78,300
$30.42 P/Share
|
|
Oct 05
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
1,389
-25.7%
|
$308,358
$222.46 P/Share
|
|
Oct 05
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+20.45%
|
$30,558
$22.3 P/Share
|
|
Oct 02
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
717
-15.15%
|
$161,325
$225.0 P/Share
|
|
Oct 02
2020
|
Andrew Turitz EVP, CORPORATE DEVELOPMENT |
BUY
Exercise of conversion of derivative security
|
Direct |
717
+13.16%
|
$27,246
$38.55 P/Share
|
|
Oct 01
2020
|
Lewis Levy Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,670
-23.35%
|
$592,740
$222.86 P/Share
|
|
Oct 01
2020
|
Lewis Levy Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,670
+11.05%
|
$98,790
$37.0 P/Share
|
|
Oct 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-31.13%
|
$1,332,000
$222.86 P/Share
|
|
Oct 01
2020
|
Stephany Verstraete CHIEF MARKETING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+23.74%
|
$132,000
$22.3 P/Share
|
|
Sep 25
2020
|
William H. Frist |
SELL
Open market or private sale
|
Direct |
740
-12.02%
|
$153,920
$208.5 P/Share
|
|
Sep 25
2020
|
William H. Frist |
BUY
Exercise of conversion of derivative security
|
Direct |
740
+10.73%
|
$4,440
$6.01 P/Share
|
|
Sep 18
2020
|
William H. Frist |
SELL
Open market or private sale
|
Direct |
740
-12.02%
|
$148,000
$200.89 P/Share
|
|
Sep 18
2020
|
William H. Frist |
BUY
Exercise of conversion of derivative security
|
Direct |
740
+10.73%
|
$4,440
$6.01 P/Share
|
|
Sep 11
2020
|
William H. Frist |
SELL
Open market or private sale
|
Direct |
740
-12.02%
|
$147,260
$199.41 P/Share
|
|
Sep 11
2020
|
William H. Frist |
BUY
Exercise of conversion of derivative security
|
Direct |
740
+10.73%
|
$4,440
$6.01 P/Share
|